TRT Without Needles: The 5 Real Options, and the One That Isn't Testosterone
Compare prescription testosterone gels, solutions, nasal gel, oral capsules, and compounded cream without confusing needle-free treatment with needle-free monitoring.
Published 2026-09-08 · Last updated 2026-09-08
Last verified: 2026-09-08
Editorial research; not clinically reviewed
Yes — TRT without needles is real: testosterone skin gels, skin solutions, nasal gel and oral capsules have FDA-approved options. Compounded testosterone cream is a fifth format, but it is not FDA-approved. These avoid testosterone shots, not blood tests. The right choice depends on your evaluation, fertility plans, household contact and the exact product. 1,2,3,4,5,6
Best for: adult men comparing ways to avoid testosterone injections. Not for you if: you need a way to skip blood testing or a tool that can diagnose low testosterone.
By TRT Provider Guide · Last verified: September 2026 · Editorial research. This page has not been clinically reviewed.
How do the five needle-free options compare?
Four treatment formats have FDA-approved testosterone products; compounded cream is a separate, unapproved category. The main practical differences are skin-transfer precautions, the daily routine and the exact prescription. 1,2,3,4,7,8,5
FDA-approved testosterone products
| Option | Real testosterone? | FDA-approved? | Skin-application transfer concern? | How often |
|---|---|---|---|---|
| Testosterone gel (AndroGel, Testim, Vogelxo, generics) | Yes | Yes, for the approved product | Yes | Daily; exact instructions vary by product |
| Testosterone skin solution (generic, applied under the arm) | Yes | Yes | Yes | Daily |
| Testosterone nasal gel (Natesto) | Yes | Yes | No exposed skin application site | 3× daily |
| Oral testosterone capsules (Kyzatrex, Jatenzo, Tlando) | Yes | Yes | No skin application site | Product-specific; 1–2× daily with food |
Sources: current product labels and FDA product records. 1,2,3,4,7,8,9,10
Compounded testosterone — not FDA-approved
| Option | Real testosterone? | FDA-approved? | Skin-transfer concern? | How often |
|---|---|---|---|---|
| Compounded testosterone cream (e.g. Male Excel) | Yes, as described by the prescriber and pharmacy | No — compounded | Yes | Prescription-specific; Male Excel advertises twice-daily cream |
Compounded products have not undergone FDA approval for safety, effectiveness or quality. Male Excel's routine is a provider-stated example, not a schedule for every compounded cream. 5,11
Not needle-free testosterone replacement
| Option | Why it belongs in a different category |
|---|---|
| Pellets (Testopel) | Testosterone, but an in-office procedure with injected local anesthetic and an incision |
| Clomiphene / enclomiphene programs | Not testosterone replacement. Clomiphene is FDA-approved for a female ovulation indication, not low testosterone in men; enclomiphene has no FDA-approved product. |
All five real options avoid testosterone shots. None of them avoids blood tests. 6
Testosterone pellets are not one of them. And the "oral" option on several clinic menus isn't testosterone at all. 12,11,16
Which one fits you depends on who else touches your skin at home, whether you want kids soon, and why your testosterone is low in the first place — along with your health, routine and budget. The cause matters to the evaluation; it does not create a simple legal dividing line between the oral brands below. 6,1,4,7,8
There's also a catch worth saying up front: avoiding shots does not avoid blood tests. It changes what "without needles" actually means. 6
Educational information, not medical advice. Testosterone is a prescription-only Schedule III controlled substance in the United States, which means federal law treats it as a drug with real potential for misuse and it cannot be lawfully bought without a prescription. For chest pain or sudden trouble breathing, call 911 or get emergency care. A painful swollen leg needs prompt medical assessment. 17,1
TRT Provider Guide has affiliate relationships with Male Excel and Taurus Meds. We may earn a commission from eligible referrals at no extra cost to you. It does not change what we publish. One of the findings below is unflattering to a commercial partner, and we published it anyway. Read our affiliate disclosure.
TRT Provider Guide is the independent decision resource for testosterone replacement therapy — helping U.S. adults understand how low testosterone is evaluated, compare online and local care models and providers, and choose the next step that fits their health needs, fertility plans, budget, state, and care preferences, with every material claim verified and dated.
This page is written for adult men being evaluated for low testosterone. It is not a guide to testosterone use in women or adolescents, gender-affirming hormone therapy, bodybuilding, or athletic performance. For gender-affirming care, use a clinician experienced in that care rather than applying this adult-male deficiency framework.
The right TRT provider is not the same for every person — it depends on whether low testosterone has been properly evaluated, your symptoms and health history, your fertility plans, your state, your insurance or cash-pay preference, your treatment-format preference, your budget, and whether online or in-person care is the better starting point. Some situations belong with primary care, urology, endocrinology, reproductive urology, or urgent or emergency care when the symptoms warrant it. Because a general answer cannot resolve those for you, use TRT Provider Guide's Find My TRT Path tool to map your situation to the right care route and the questions to ask before you pay.
What we actually verified — September 8, 2026: product labels and FDA marketing records; the research and guidance cited below; published pharmacy prices; and provider-stated fees, state exclusions and policies. We did not purchase care, verify pharmacy stock or test a treatment. The full verification record separates what the sources establish from what still needs a personal quote.
What are the real options for TRT without needles?
There are five needle-free ways to take prescription testosterone in the U.S.: skin gel, skin solution, nasal gel, oral capsules, and compounded cream. The first four have FDA-approved products with published labels; compounded cream is made by a pharmacy for a patient and is not FDA-approved. Pellets are often listed as a needle-free option, but they are implanted through a small incision with injected local anesthetic. 1,2,3,4,5,12
Let's take them one at a time, because "needle-free" is where the similarities end.
Testosterone gel. AndroGel 1.62%, Testim, Vogelxo and several generics deliver testosterone through the skin. You rub it on once a day. Different gels are not interchangeable — strengths and application sites differ by product, and copying one product's instructions onto another is a genuine mistake people make. Fortesta is an older brand name you may still see: FDA now lists the brand as discontinued. 1,9,10,18
Testosterone skin solution. Worth knowing about because it is easy to miss. This is a separate approved product from gel — a liquid applied under the arm, with its own label and its own instructions. If a gel doesn't suit you, this is a distinct option to raise with a prescriber, not a rebrand of the same thing. 2
Testosterone nasal gel. Natesto is an FDA-approved nasal testosterone product in the U.S., used three times a day. Three doses a day sounds like a downgrade. Its lack of an exposed skin application site can matter to someone worried about transfer — but that does not make it the best option for everyone with that concern. 3
Oral testosterone capsules. Real testosterone in a pill: Kyzatrex, Jatenzo and Tlando. All three are testosterone undecanoate, a form of testosterone absorbed mainly through the lymph system rather than straight through the liver. They must be taken with food. Their food effects, prescribing instructions and monitoring details differ, which we'll come back to. 4,7,8
Compounded testosterone cream. A pharmacy mixes testosterone powder into a cream base for a patient. Male Excel is one telehealth example. It's real testosterone. It is not an FDA-approved product, which means FDA has not reviewed that specific preparation for safety, effectiveness or quality. 5,19
Do these work as well as shots?
FDA-approved non-injection products have clinical-trial evidence that they can bring testosterone into the studied normal range. That does not prove every format works equally well for every person, or that a compounded cream has the same evidence as an approved gel or injection. 1,4,3,5
The honest differences aren't about power. They're about routine, transfer, absorption and money. Skin absorption and application instructions differ by product; a treatment that seems not to be working needs a review of symptoms, blood results and how it is used. That's a blood-test conversation with your prescriber, not a reason to write off the format. 1,2,20
For the broader format comparison, see TRT treatment options. For the two-format decision, see injections vs. gel.
Does "no needles" mean no blood tests?
No — avoiding testosterone injections does not avoid blood draws. Low testosterone is evaluated with blood tests, and every treatment on this page requires blood monitoring afterward. If the needle you're actually afraid of is the one at the lab, this is the part you need to plan for — and it's worth saying out loud to your care team rather than quietly avoiding the appointment. 6,4,3
Here's what that catch means in practice.
Two separate morning blood tests come before treatment. The American Urological Association's guideline is specific: diagnosis should be made only after two total testosterone measurements taken on separate occasions, both drawn in the early morning, preferably at the same lab using the same method. And a low number alone isn't enough — the diagnosis is only made when low testosterone is combined with symptoms or signs. 20
That isn't just a guideline talking. The drug's own manufacturer says the same thing. Kyzatrex's FDA label instructs prescribers, before starting, to confirm the diagnosis by making sure testosterone was measured in the morning on at least two separate days and was below the normal range both times. 4
A symptom quiz satisfies neither.
More blood draws come after you start. Product labels direct clinicians to check things like hematocrit — the share of your blood made up of red cells, which testosterone can push up — but the schedule is not the same for every product. Kyzatrex and Jatenzo specify checks about every three months; AndroGel and Natesto describe a baseline check, another at three to six months, then annual checks. Tlando specifies about every three months in the first year and every six months after that. Your clinician may need closer checks. 4,7,1,3,8
PSA (a prostate blood marker), lipids, blood pressure and other checks depend on the product and your health; prostate monitoring also involves age, risk and a discussion with your clinician. This is not busywork. An increased red-cell mass can raise clot risk, and that's monitored for a reason. 6,4
So what do you do if blood draws are the actual problem?
Say so. Directly, to whoever draws your blood and to whoever prescribes. Three situations get three different answers:
- "I can't inject myself." This page is for you. The formats below solve it.
- "I'm afraid of blood draws too." That's a common fear with real, practical accommodations — such as lying down if you feel faint, and telling the person taking your blood before the appointment. Tell them at booking, not at the chair. 21
- "I've only had one low result." One low result alone does not establish the diagnosis. The next step is repeat early-morning testing and a clinician's review of your symptoms or signs, not a treatment sale. 20,6
Some services offer a home kit; others arrange a phlebotomist — a person trained to draw blood — to visit your home. That's a real convenience. A finger-prick test uses a lancet and a visiting blood draw uses a needle: home collection is not a needle-free blood test, and no one should let you believe otherwise. 22
Use the TRT blood-test guide to check which questions to ask about repeat testing and follow-up.
If I use a gel or cream, can it get on my wife or my kids?
Yes — and the FDA takes it seriously enough to require a boxed warning on testosterone gels for secondary exposure. Children exposed through skin contact have developed enlarged genitals, early pubic hair and advanced bone age. The nasal gel and the oral capsules carry no such warning, because nothing sits on your skin. 1,3,4
This is a reasonable fear, and it deserves an answer from the actual label. So here it is.
The current AndroGel 1.62% prescribing information opens with a boxed warning — the FDA's strongest label warning — titled WARNING: SECONDARY EXPOSURE TO TESTOSTERONE. It states that virilization has been reported in children secondarily exposed to testosterone gel, that children should avoid contact with unwashed or unclothed application sites, and that prescribers should tell patients to follow the instructions strictly. 1
Where it came from: the FDA required this in 2009 after reports of children exposed through skin contact. Effects included enlarged genitals, early pubic hair, advanced bone age, increased libido and aggressive behavior. In most reports with a known outcome, the effects regressed once exposure stopped. In a few cases they didn't fully — enlarged genitals did not fully return to age-appropriate size, and bone age stayed modestly ahead. 23
Those reports do not tell us how often exposure happens. They are not a small matter if one of the children is your kid.
Two things you've probably read that are wrong
"The FDA removed the boxed warning from testosterone in 2025." Not this one. On February 28, 2025, the FDA did announce class-wide labeling changes after the TRAVERSE cardiovascular trial — it recommended adding the trial's results to all testosterone labels, keeping the "limitation of use" language about age-related low testosterone, and removing the cardiovascular language from the boxed warning. It also required new blood-pressure warnings. 24
That was about heart risk. On the gel labels, the cardiovascular language came out of a different section entirely — AndroGel's own revision history shows "Cardiovascular Risk (5.5) Removed 07/2025" under Warnings and Precautions. The secondary-exposure boxed warning stayed exactly where it was. You can open the label today and read it. 1
"Just wash your hands and you're fine." The label's own precautions go further than that: wash hands with soap and water right after applying, cover the site with clothing once it's dry, and wash the site thoroughly before skin-to-skin contact. Those precautions reduce risk; they do not make exposure impossible. They also have to be followed every day the product is used, including by a tired person. 1
The sentence that decides this for a lot of men
Among needle-free testosterone options, nasal gel and oral capsules are not applied to an exposed skin site and do not carry the skin-transfer boxed warning. 3,4,7,8
If there's a toddler in your house or a pregnant partner, that isn't a footnote. That's a reason to discuss a non-skin-applied product before choosing — not a promise that one format is automatically right for you. 1,3,4
Is there a real testosterone pill I can actually get?
Yes — Kyzatrex, Jatenzo and Tlando are FDA-approved oral testosterone undecanoate capsules: real testosterone, taken with food. Their current labels all show removal of the blood-pressure boxed warning and the age-related or nonstructural hypogonadism contraindication in July 2025. They still have blood-pressure warnings, and the versions checked here still say safety and efficacy in age-related hypogonadism have not been established. 4,7,8
Read the current label, not an old comparison. The difference matters before you ask for a pill.
Some men have what's often called functional or age-related low testosterone — levels changed alongside age, weight, sleep or illness, rather than a specific condition like Klinefelter syndrome, a pituitary injury, or testicles damaged by chemotherapy. The cause needs a clinical evaluation; this page cannot identify it for you. 6,4
What do the current oral-product labels actually say?
Label check: September 8, 2026. This compares the current published versions, not older boxed warnings copied into clinic articles.
A contraindication is a label's instruction not to use a drug in a particular situation. Removing it is not the same as proving benefit for that group.
| Product | Label revision checked | Blood-pressure boxed warning | Age-related / nonstructural contraindication | What still matters |
|---|---|---|---|---|
| Kyzatrex | August 2026 | Removed July 2025 | Removed July 2025 | Blood-pressure warning remains; age-related safety and efficacy still not established in this version |
| Jatenzo | September 2025 | Removed July 2025 | Removed July 2025 | Blood-pressure warning remains; age-related safety and efficacy still not established in this version |
| Tlando | February 2026 | Removed July 2025 | Removed July 2025 | Blood-pressure warning remains; age-related safety and efficacy still not established in this version |
Kyzatrex used to have both restrictions. It doesn't anymore — and neither do the other two current labels. Its current label, revised August 2026, lists the nonstructural/genetic-condition contraindication and the blood-pressure boxed warning as removed in July 2025. 4,7,8
So Kyzatrex now carries no boxed warning at all. Blood pressure moved into Warnings and Precautions with real numbers attached: mean systolic/diastolic increases of 1.7/0.6 mm Hg at four months and 1.8/0.6 at six. For men already on blood-pressure medication, 3.4/0.7 at four months and 3.1/1.0 at six. It is not recommended for anyone whose high blood pressure isn't under control. These are average changes in the study, not a limit on what can happen to one person. 4
Same active drug, different products and instructions — but not opposite answers based on that removed contraindication. Removing a boxed warning does not mean removing all risk or approving anti-aging use. In June 2026, HHS announced requested further labeling changes; a request is not proof that every product label has already changed. 4,7,8,25
A few more things worth knowing before you ask for a pill
It works. In the trial behind Kyzatrex's approval, 122 of 139 men — 88%, with a confidence interval of 82% to 93% — had average testosterone land in the normal range of 222–800 ng/dL by day 90. That was the study's laboratory endpoint, not a personal treatment target or proof that every symptom will improve. 4
"Twice daily" isn't automatic. Plenty of articles say oral testosterone is always twice a day. Kyzatrex's label includes a once-daily morning-only option at its lowest maintenance dose. Your regimen is your prescriber's call, not a blog's. 4
Food isn't a suggestion. With breakfasts containing 16%, 33% and 45% fat, testosterone exposure from Kyzatrex rose 37%, 87% and 94% respectively compared with taking it on an empty stomach. Taking it with only black coffee can change how much is absorbed. This is a reason to follow the product's food instructions, not to design your own high-fat diet or change a dose. 4
One limitation they publish and we won't bury: the Kyzatrex label states that its clinical studies did not include any patients 65 years of age or older, and that there aren't enough long-term safety data in older patients to assess potential added risk of cardiovascular disease and prostate cancer. There is an internal conflict: section 14 gives an age range of 22–66, despite section 8.5's statement that no participants were 65 or older. We won't turn those conflicting statements into a confident claim about how many older men were studied. 4
A new strength appears in the product listings. Kyzatrex's DailyMed record lists a 50 mg capsule with a marketing start date of August 18, 2026 — three weeks before this page was verified. That listing is not a new starting-dose recommendation or proof of pharmacy stock. Separately, the label's own listings show a marketing end date of September 29, 2025 for both 100 mg bottle sizes, while 150 mg and 200 mg show none. Worth asking your pharmacy which strengths they can actually get. 4
Still deciding whether a pill, a gel or a nasal option fits your life?
→ Map your situation with Find My TRT Path — use it to explore a care route and the questions to bring to a prescriber. It's educational, not a diagnosis, and it won't tell you whether you qualify for anything.
How does nasal testosterone compare — and is it really the fertility option?
Natesto is an FDA-approved testosterone nasal gel in the U.S., used three times a day, with no skin-transfer boxed warning. A small trial suggests that many participants maintained sperm measures during treatment, but it is not FDA-approved for preserving fertility. Nobody should promise you that it will. 3,26
Nasal health matters too. Natesto's label identifies nasal conditions, some past nasal surgery or injury, and other nasal medicines as issues to review with the prescriber. Bring those details to the appointment; no skin-transfer warning does not mean no product-specific restrictions. 3
Start with the part that isn't optional.
Any testosterone you take from outside your body can shut down sperm production. Gel, cream, capsule, nasal, pellet, shot — all of it. The mechanism is the same: your brain sees enough testosterone in the blood and can reduce the signals that tell your testicles to make more, and those same signals drive sperm production. 27,3
Kyzatrex's label puts it plainly: with large doses of testosterone from outside the body, sperm production may be suppressed, possibly affecting semen measures including sperm count. Reduced fertility has been seen in some men on testosterone replacement. And the label adds that the impact on fertility may be irreversible. 4
That is a warning about possible harm, not a prediction that every man will become infertile or that recovery is impossible. 4,27
Why nasal is different, and exactly how much
Natesto is short-acting. Testosterone goes up, then comes back down between doses; researchers have proposed that this may allow less continuous suppression of the body's hormone signals. That's the theory, not a guarantee. Here's what the trial actually found. 28,3
Researchers at the University of Miami ran a single-center, open-label trial of 60 men with low testosterone treated with Natesto for six months. Total motile sperm count stayed above 5 million in 88.4% of men at three months and 93.9% at six months. Men also reported statistically significant improvements in sexual desire and overall satisfaction at six months. Of the 60 enrolled men, 44 completed the three-month visit and 33 completed six months. The study excluded men with low baseline total motile sperm counts, and those percentages are not pregnancy rates. 26
Now the parts a sales page would skip.
A companion conference report recorded one man who became azoospermic — no measurable sperm — and three with severe oligospermia, meaning very low sperm counts. Ten men dropped out because of nasal irritation. And it was one site, one arm, no control group, six months. 28,26
The investigators' own conclusion is the right one to end on: longer studies beyond six months are needed before nasal testosterone gel can be safely prescribed for men interested in fertility. 26
So here's where we land, honestly. If having children in the next few years matters to you, the first call is a urologist or reproductive urologist — not a general online TRT program, and not this page's provider list. There are treatments built specifically around preserving fertility, and a specialist can walk you through them with your labs in hand. Nasal testosterone is worth raising in that conversation. It is not a substitute for having it. The AUA/ASRM male-infertility guideline says testosterone monotherapy — testosterone used on its own — should not be prescribed for a man interested in current or future fertility. See TRT and fertility before choosing a format. 27
Is the "oral TRT" some clinics advertise actually testosterone?
Sometimes, no: an "oral" option inside a testosterone menu may contain clomiphene or enclomiphene, drugs that can stimulate the body's own testosterone production in selected patients. These are selective estrogen receptor modulators, or SERMs, not testosterone replacement. Neither has an FDA-approved indication for treating low testosterone in men, and they do not guarantee preserved fertility. 13,14,27
This is awkward to publish about a commercial partner. We're publishing it anyway.
Male Excel — the provider whose costs we examine later on this page, and a company we have an affiliate relationship with — runs a pricing page headed "3 TRT Solutions: Injectable, Topical or Oral." We read it on September 8, 2026. The Oral card is titled "Triclozene™ (Clomiphene Citrate with Thyroid)." The page describes it as a proprietary formula featuring clomiphene citrate and two thyroid-boosting ingredients "to help stimulate your body's natural testosterone production." The product page sits at the URL /treatments/clomiphene-for-men/. 11,29
Male Excel isn't hiding it. The ingredient is right there on the card. The problem is structural: a man scanning a page headed "3 TRT Solutions" who sees an Oral option at the lowest price may conclude that the price buys testosterone capsules. It doesn't. That's a different drug doing a different job. There is also a price conflict on the same page: $120/month on one Triclozene card and a $95/month starting price farther down, before the required membership. Ask which quote applies; neither is a quote for oral testosterone undecanoate. 11
Taurus Meds lists an oral option as enclomiphene. Hims, part of Hims & Hers, markets a compounded enclomiphene-based product; Marius Pharmaceuticals announced an agreement to bring branded oral Kyzatrex to the platform in September 2025. The Hims page still marked Kyzatrex as coming in 2026 when checked, so that announcement is not proof that a patient can fill it there today. Different menus; the same useful question about what is actually in the pill. 16,30,31
To be fair to all three, the distinction cuts both ways
The trade is real, and sometimes it favors a SERM. A fertility-focused clinician may consider medicines that stimulate testosterone production rather than replacing it. For a 34-year-old who wants kids in two years, that may genuinely be a better care discussion than choosing among testosterone products. That's a conversation worth having — without a promise about sperm count, pregnancy or recovery. 27
The umbrella term needs care. The AUA guideline discusses testosterone treatment alongside alternatives such as SERMs, hCG and aromatase inhibitors. These can have different purposes and evidence; hCG is a hormone medicine, and aromatase inhibitors reduce conversion of testosterone to estrogen. Grouping options that may raise testosterone does not make them all testosterone replacement. 20,27
For example, approved hCG products such as Pregnyl have a specific indication for selected cases of male hypogonadotropic hypogonadism — low testosterone caused by inadequate pituitary hormone signals. Pregnyl is injected, not needle-free TRT. It is not an FDA-approved promise of fertility preservation for every man taking testosterone. 32
Calling a SERM replacement, or filing it under "TRT" next to two actual testosterone products without making the difference clear, can mislead the reader.
And the regulatory ground is thinner than the marketing suggests. There is no FDA-approved enclomiphene product. FDA's advisory materials describe a 2015 complete response letter for Androxal, meaning the application was not approved in that form, with concerns about proof of clinical benefit and aspects of the studies. A 2022 advisory committee voted 8–4 against adding enclomiphene to the 503A Bulks List. 14,33
That vote was not itself a blanket ban on all compounding. FDA's May 14, 2026 list still puts enclomiphene citrate in Category 1: under evaluation. Compounding with Category 1 substances may fall within FDA's interim enforcement policy when its conditions are met; this does not make the product FDA-approved. Clomiphene itself is FDA-approved, but for ovulatory dysfunction in women desiring pregnancy; using it for low testosterone in men is off-label. 15,34,13
The one-line test: ask any clinic "Does the oral product you'd prescribe contain testosterone?" If the answer isn't a straight yes, it's a different drug. Which might still be right for you — but you should know which one you're buying.
What doesn't count as needle-free?
Older articles and clinic pages can list options that are discontinued, or that involve a needle you didn't notice. Pellets require injected local anesthetic and an incision, and autoinjectors still contain a needle. FDA lists the reviewed patch and buccal products as discontinued; that status does not by itself mean they were withdrawn for safety reasons. 12,35,36,37
| What you'll see recommended | What's actually true |
|---|---|
| Testosterone pellets (Testopel) | Pellets are implanted under the skin in the office. The procedure uses injected local anesthetic and an incision. Fewer self-injections, but not needle-free. 12 |
| Testosterone patch (Androderm) | FDA lists it as discontinued. Its record states that the 2 mg and 4 mg products were not discontinued for safety or effectiveness reasons. It is not a routine current U.S. option to plan around. 36 |
| Buccal system (Striant) | The gum-and-cheek system. Also discontinued. It shows up in articles written years ago. 37 |
| Autoinjector (Xyosted) | A different injection device. The manufacturer's own instructions describe a needle end and an injection. It's still a shot. 35 |
| Needle-free "jet injectors" | Devices marketed for pushing medication through skin with pressure. Vendors advertise them for testosterone. We could not verify that any such device is authorized for that specific drug-and-device use, and FDA establishment registration is not the same as approval or clearance. We're not recommending one, and we're not telling you it's illegal — we're telling you we couldn't confirm it, which is its own answer. 38 |
| "Natural testosterone boosters" | Supplements are not testosterone replacement. They are not a substitute for a proper evaluation of suspected low testosterone. 6 |
What does TRT without needles actually cost?
There is no verified all-in first-year price range for every needle-free option. A pharmacy discount price covers a particular medicine and quantity, while a managed program may add consultation, membership, testing and shipping charges. Compare the same days of medicine and the same care costs before calling one path cheaper.
Prices checked September 8, 2026 on GoodRx and on providers' own pages. Pharmacy prices vary by ZIP code and change often; treat these as a starting point for your own check, not a quote. 39,40,41,42,11
FDA-approved products: medicine prices, not complete care prices
| Path | Published price checked | What that number covers | What it does not establish |
|---|---|---|---|
| Generic testosterone gel, your own prescriber | $42.87 in the GoodRx dosage-price table | One 88-g pump of 1.62% generic gel | Your days supplied, pharmacy quote, visits, tests, shipping or any paid discount membership 39 |
| Generic testosterone skin solution, your own prescriber | $54.84 in the GoodRx dosage-price table | One 90-mL bottle at 30 mg/1.5 mL | Your days supplied and complete care cost 39 |
| Brand AndroGel 1.62%, your own prescriber | A brand-specific quote is needed | The GoodRx AndroGel page defaults to a generic selection | A generic coupon on a brand-named page is not a verified brand price 40 |
| Natesto, your own prescriber | $165 on GoodRx for three 11-g dispensers; manufacturer cash option $140 per eligible 20–30-day fill | Different programs and fill quantities; do not treat them as the same offer | Visits, tests and eligibility; days supplied must match before comparison 41,43 |
| Jatenzo, your own prescriber | $1,092.62 on GoodRx | 60 capsules at 237 mg | Your prescribed quantity, insurance cost or complete care total 42 |
These strengths identify the price examples; they are not recommended doses. No complete annual medication total is shown without a confirmed days-supply calculation. For Kyzatrex or Tlando, request a quote for the exact prescription rather than borrowing another capsule's price.
Compounded cream: a program-fee example, not an FDA-approved product
| Path | To start | Advertised medication-program rate | Required membership | Calculable subtotal |
|---|---|---|---|---|
| Male Excel compounded cream program | $99 consultation; the provider describes an included home hormone test | $132/month starting rate for the advertised cream-with-thyroid package, supplied for 60 days and billed every other month | $99/month | $231/month recurring at those rates; $2,871 for the initial consultation plus 12 months of those advertised rates, before shipping, any extra tests or other charges |
The provider describes the offer as a cream-with-thyroid package, not a universal testosterone-only price. Ask the clinician why any thyroid medicine is being proposed and what evaluation supports it; a bundle does not establish that you need each medicine. 11,19,22
Three things about that table.
One — the Natesto row has a trap in it, and we're flagging it rather than hiding it. Natesto is used three times a day, so a fill may cover 20 to 30 days, not a calendar month. Before you compare it to anything else, ask the pharmacy how many days that fill actually covers. We're not going to annualize a number we can't pin to a period, and neither should any page quoting you a "monthly" price for it. 3,43
The manufacturer's commercial-insurance card currently advertises as little as $0, not a guaranteed price for everyone, with a $3,500 annual maximum benefit and other eligibility limits. The commercial-insurance card excludes government programs such as Medicare and Medicaid. Its separate $140 cash option covers eligible 20–30-day fills and permits up to 12 refills under the published terms. Those are medicine programs, not payment for your visits or tests. 43
Two — the Male Excel number is our arithmetic, not their quote. Their published rates are $99 to start, $132 a month for the advertised topical package, and $99 a month for the required Medical Membership. That's $231 a month recurring. The $99 start fee plus twelve months at those rates is $2,871. But medication ships as a 60-day supply billed every other month, so six shipments cover 360 days rather than 365, shipping is extra, and a dose increase can raise the medication price. The honest way to say it: the advertised recurring cost is $231/month, and $2,871 is a billing subtotal — not $132/month and not a verified complete first-year cost. 11,22,44
Three — what the cheap column leaves out. A low generic-gel price assumes you have a prescriber who'll write it, a pharmacy that stocks it, insurance or cash for the visits and labs, and the willingness to manage your refills. None of that is automatically included in the coupon. It's just not billed by one company. Some discount offers also require a paid membership; include that fee when it applies. 39,40
Before you compare any two quotes, get these nine things
- Exact drug name and strength on the prescription
- FDA-approved or compounded — and if compounded, which pharmacy
- Days supplied per fill, not "per month"
- Whether the initial consultation or home test is charged even if treatment isn't prescribed
- Which labs are included, whether both early-morning diagnostic tests are covered, how often follow-up testing occurs, and who orders it
- Membership or access fees, separately from medication
- Shipping, and refill lead time
- Billing schedule, minimum term, cancellation cutoff and refund policy
- What happens to the price if your dose goes up
Copy this into your quote request: "Please itemize the medicine, days supplied, required membership, visits, repeat morning testing, follow-up labs, shipping and any other required charges. Include the refill and cancellation deadlines, refund rules, and the cost if no prescription is issued."
Complete first-year cost = the initial evaluation + all medicine needed for the same 365-day period + all required membership, visit, laboratory, shipping and other fees. An unknown required charge stays unknown — it is not $0.
Straight admission: Male Excel's needle-free testosterone is a compounded cream, not an FDA-approved product. If having an FDA-approved product matters most to you, a generic testosterone gel or an oral capsule from a retail pharmacy through your own prescriber is the better care route to explore. It may also cost less, but that takes an actual quote. That's a real trade-off and we're not going to pretend otherwise. 5,19
Male Excel advertises a managed program with home testing, ongoing provider access, refills and unlimited messaging with its support team. That can be a convenience worth paying for. But compounding does not make the program available in every state, establish that every lab is included or protect it from stock problems. The AUA guideline recommends commercially manufactured testosterone rather than compounded testosterone when possible; convenience alone does not prove a medical need for a compounded preparation. 11,22,44,20
What does Male Excel actually disclose before you pay?
These are provider-stated facts checked September 8, 2026, not an independent check of a particular clinician, pharmacy order or patient account.
| Decision point | What the official pages say | What still needs a personal answer |
|---|---|---|
| State access | The FAQ excludes Alabama, Alaska, Arkansas, Connecticut, Hawaii, Idaho, Louisiana, Minnesota, Mississippi, New Hampshire and Rhode Island. | Whether a properly authorized clinician can treat you where you will be located. 22 |
| Testing and follow-up | The starting consultation includes a home hormone test; the FAQ mentions possible blood tests at six months and one year. | Whether a second early-morning diagnostic test, baseline safety tests and all product-appropriate follow-up tests are ordered and included. The published FAQ does not establish a complete monitoring plan. 22,19 |
| Clinician and support access | The membership page advertises ongoing provider care, unlimited support-team messaging and unlimited provider e-visits. | Your assigned clinician's credentials, state authority, appointment availability and response times. We did not independently verify those for an individual patient. 11 |
| Dispensing pharmacy | The FAQ names Anazao Health Corp and WellDyneRx-FL as pharmacy partners. | Which pharmacy will make and dispense your cream, the prescription's concentration and that pharmacy's authority to serve your state. Naming partners is not an order-specific pharmacy or license check. 22 |
| Renewal and cancellation | The FAQ describes a 48-hour response window after a renewal reminder; it also says there is no contract and cancellation is possible anytime. | The exact cutoff that prevents the next charge, whether an affirmative refill approval is required, and written confirmation of cancellation. 22 |
| Refunds and shipping | The terms say sales are final, including subscription fees unless otherwise specified, and shipping/handling charges can apply. | The actual shipping charge, any applicable exception and what happens if treatment is not prescribed. 44 |
| Insurance and records | The program's terms describe cash payment rather than billing insurance. | How you receive your laboratory results and medical records, including after cancellation; the reviewed pages did not establish that process. 44 |
Cancellation stops future services under the applicable terms; it does not turn a nonrefundable charge into a refund.
They also disclose things worth reading before you pay. Their own page states that based on DEA and state laws, your treatment plan may require an in-person exam. Their FAQ states the renewal window plainly: before the end of your 60-day supply you'll get a reminder, and you have 48 hours to act before you're billed and treatment ships. That's a short window. Elsewhere the FAQ describes approving a refill assessment, so ask which step actually controls your next charge and shipment. 19,22
→ Check Male Excel's fees, renewal terms and open questions — the cost guide helps you compare the cream, membership and consultation charges before deciding whether to request a personal quote.
If that's not you, skip it. Want an FDA-approved product specifically? Concerned about skin contact with a small child or pregnant partner? Want to use insurance? Discuss the appropriate FDA-approved product with your own clinician and pharmacy, and check the exact medicine with your plan. The online-versus-local care guide can help you compare those care routes. 1,4
My pharmacy keeps running out. Does going needle-free fix that?
Changing products may avoid a shortage of a particular injectable product, but it does not guarantee supply of the replacement. The current shortage bulletin discussed here is for testosterone cypionate injection, not proof that every oral, nasal or topical product is in stock. Changing formulations is a prescribing decision made with your clinician — not something you can arrange around them. 45
Here's the current picture, without any drama attached to it.
The American Society of Health-System Pharmacists maintains a shortage bulletin for testosterone cypionate injection that was created in 2019 and was updated on September 3, 2026. It's manufacturer-by-manufacturer: Pfizer's Depo-Testosterone products were on back order because of manufacturing delays, with no estimated release date. Sun Pharma discontinued its products in late 2023. Eugia, Hikma, Padagis and Pfizer generic products, and Cipla's 1-mL product, were listed as available; Cipla's 10-mL product had been discontinued in 2022. 45
That can help explain why availability feels random. Pharmacies may have access to different manufacturers, wholesalers or stock. A national bulletin is not a check of your pharmacy's shelves.
Oral, nasal and topical products are different products with their own supply. This injection bulletin does not establish their stock or shortage status. Ask your pharmacy about the exact prescription rather than assuming "needle-free" means available. 45
We're not going to turn this into a reason to hurry. A drug shortage is a supply problem, not a sales event. If it's affecting you, the useful move is a conversation with your prescriber about whether a different format fits your situation — and asking your pharmacy which manufacturers they can actually order.
Can I get needle-free TRT prescribed online?
Yes, when the clinician and prescription meet federal and state requirements. Testosterone is a Schedule III controlled substance, and federal telemedicine flexibilities allowing remote prescribing without a prior in-person exam run through December 31, 2026. That is a temporary federal permission, not a guarantee that every clinic can treat every patient remotely. 17,46,47
The DEA and HHS have extended the full set of pandemic-era telemedicine flexibilities for controlled medications through the end of 2026. Under them, a DEA-registered practitioner can prescribe a Schedule II–V controlled substance by telemedicine without a prior in-person evaluation, provided the required conditions are met. 46,47
This is the fourth temporary extension. For testosterone under this pathway, the required telemedicine visit uses real-time audio and video; a form or ordinary message exchange alone is not that visit. The separate audio-only exception concerns certain opioid-use-disorder medicines, not testosterone. 47
Why this matters for testosterone: changing from a shot to a gel or capsule does not change its controlled-substance status. The federal rule is one part of whether an online prescription is lawful; the clinician's authority and your state's requirements still matter. 17,47
Two things to hold onto:
A remote form is not a guarantee of a lawful prescription. State requirements and prescriber authority still apply on top of the federal rule. Male Excel's own site says as much — that DEA and state laws may require an in-person exam. Any program that promises approval before evaluating you is telling you something it can't know. 47,19
Ask this, don't panic about it: "If the federal telemedicine rules change, what happens to my refills?" That's a fair question to any online program, and a good one to ask before you pay. We'll re-check this section before the end of 2026 and update the date on this page when we do.
How do I know I actually need this before I pay for anything?
Low testosterone is diagnosed with symptoms or signs plus consistently low testosterone confirmed with two separate early-morning blood tests — not with one test, and not with a symptom quiz. The AUA uses total testosterone below 300 ng/dL as a reasonable cut-off, not a diagnosis on its own. Total testosterone means all the testosterone in your blood, bound and unbound. 20,6
The AUA guideline is specific on all three points: use a total testosterone below 300 ng/dL as a reasonable cut-off (a moderate recommendation, evidence grade B); make the diagnosis only after two morning measurements on separate occasions (a strong recommendation, evidence grade A); and make the clinical diagnosis only when low levels are combined with symptoms or signs. 20
And the 300 number isn't a bright line. The result has to be interpreted with the assay, the laboratory's reference range, symptoms or signs and the clinical setting. The Endocrine Society recommends accurate testing and a repeat morning fasting measurement; selected situations also call for a reliable free-testosterone assessment. We're not going to interpret your labs, and no honest page will. 6,48
Who should not start with an online program
If any of these apply, get a clinician-led assessment before choosing an online program. Not because online care is bad — because your situation may need an exam, closer monitoring or a specialist: 6,4,27
- Very low or clearly abnormal test results
- Suspected pituitary or testicular disease
- Infertility, or wanting children in the near term
- A history of prostate or breast cancer
- Elevated hematocrit
- Untreated severe sleep apnea
- A recent heart attack, stroke or blood clot
- Blood pressure that isn't under control
Care route: primary care, urology, endocrinology, or reproductive urology, depending on which one applies. Urgent or emergency care if symptoms warrant it.
So which needle-free option should you choose?
It depends on four things: who's in your household, whether you want children soon, why your testosterone is low, and whether you'd rather pay less or handle less. There is no single best needle-free format, and any page that names one without asking those four questions is guessing. 6,1,27
These are editorial starting points for a clinical discussion, not product prescriptions or medical eligibility decisions.
| If this is you | Start here | Why |
|---|---|---|
| Young child or pregnant partner at home | Discuss a non-skin-applied option with your prescriber, and review your full health history | Nasal gel and oral capsules do not have an exposed skin application site or the skin-transfer boxed warning. 1,3,4 |
| Want children in the next few years | A urologist or reproductive urologist first — not a general TRT sales pathway | Every testosterone format can suppress sperm production. Fertility-focused care comes before choosing a product. 27 |
| Low testosterone came on with age or weight, and you want a pill | Ask the clinician to evaluate the cause and review the current label for the exact product | Kyzatrex, Jatenzo and Tlando all removed the old contraindication; their checked labels still describe an age-related evidence limitation. 4,7,8 |
| You have insurance and a prescriber you like | Check the exact FDA-approved product with your pharmacy and plan | A generic gel or solution is worth pricing, but a coupon is not a complete annual quote. 39 |
| You want home-based care and are considering compounded cream | Read the Male Excel cost guide, then ask a clinician whether compounding is appropriate | The advertised recurring subtotal is $231/month; state exclusions, testing, transfer precautions and refill terms still matter. 11,22,20 |
| Blood pressure isn't controlled yet | A clinician-led assessment before choosing treatment | The oral testosterone undecanoate labels do not recommend use with uncontrolled hypertension. 4,7,8 |
| You're not sure yet | Find My TRT Path | Explore a care route and questions to ask before paying; it is not a medical product-selection tool. |
Notice that most of those rows don't point at a commercial partner. That isn't modesty. It's what the evidence supports.
→ Get your care route with Find My TRT Path — explore the questions that matter before choosing a provider. Educational only. It does not diagnose low testosterone, choose a medication for you, determine eligibility, or guarantee a prescription.
What did we actually verify?
On September 8, 2026, we read the sources below ourselves. This was public-source research, not a hands-on treatment review, and a provider's published statement is labeled as such.
- The current Kyzatrex prescribing information on DailyMed (label revised 8/2026), including its Recent Major Changes, removed contraindication, removed boxed warning, blood-pressure data, day-90 efficacy, food effect, geriatric limitation and NDC listings. We also checked the conflicting age statements rather than treating them as settled. 4
- The current AndroGel 1.62% prescribing information, including the secondary-exposure boxed warning and the July 2025 revision history, plus the FDA's 2009 safety-labeling letter. 1,23
- The current Jatenzo and Tlando prescribing information, including both products' removed boxed warnings and contraindications. 7,8
- The Natesto and topical-solution labels; FDA records for the named gels, patch and buccal system; and the manufacturer's pellet and autoinjector instructions. 3,2,18,9,10,36,37,12,35
- Male Excel's pricing, cream, FAQ and terms pages — published prices, required membership, state exclusions, pharmacy partners, renewal window, compounding disclosure, cancellation/refund terms and in-person-exam disclosure. 11,19,22,44
- GoodRx's quantity-specific discount prices and the Natesto manufacturer's distinct savings programs; we did not treat a generic selection as brand AndroGel or a fill as a calendar month. 39,40,41,42,43
- The ASHP testosterone cypionate shortage bulletin, manufacturer by manufacturer, and the DEA/HHS temporary extension and its conditions. 45,46,47
- The AUA's published diagnostic recommendations, the Endocrine Society's guidance and July 2026 statement, the AUA/ASRM fertility guideline, and the Natesto study and companion conference report. 20,6,48,27,26,28
- The FDA's February 28, 2025 labeling statement, HHS's June 2026 announcement of requested changes, FDA advisory materials on enclomiphene, and the current 503A Category 1 list and policy. 24,25,14,33,15,34
Provider-stated, attributed, not independently confirmed:
- Male Excel's cream-strength superiority claim was not established by this research. A marketing comparison is not evidence of better clinical outcomes or equivalence to an FDA-approved product. 11,5
- Male Excel's service, clinician-access and state-coverage statements are published provider claims, not an independent check of the clinician assigned to a reader. 11,22
- Male Excel does name pharmacy partners. We did not confirm which pharmacy would dispense a particular reader's cream, inspect that prescription or independently verify order-specific licensing. 22
We could not verify, so we did not recommend:
- Whether Taurus Meds currently provides a sufficiently specified needle-free testosterone option for a recommendation here. Its program page includes a "Testosterone Gel" card, but the description repeats injection wording and does not settle the exact product or FDA-approved-versus-compounded status. Its oral enclomiphene offer is not testosterone. A page about avoiding needles should not turn that incomplete product detail into a provider recommendation. 49,16
- Whether any advertised jet injector is authorized for testosterone
- A complete patient-specific 365-day treatment cost for any path in the price table. The published prices do not settle every required visit, test, fill or fee.
- Any reader's insurance coverage, pharmacy stock, or eligibility
What we did not do: we did not try these treatments, buy a program, time a support response, check pharmacy inventory, or have a clinician review this page. A drug label is not a stock check, and a published price is not your quote.
Our full method is documented in How We Review TRT Providers.
Our editorial standards explain how evidence and commercial relationships are handled. Read the privacy policy before sharing information through site tools, or use corrections to flag a source or price that has changed.
What else should you know about TRT without needles?
The questions below cover product identity, testing, fertility, price and access. They do not replace an evaluation or settle which prescription is right for you.
Is there a TRT that isn't an injection?
Yes. Testosterone gel, testosterone skin solution, testosterone nasal gel and FDA-approved oral testosterone capsules all avoid injections, plus compounded testosterone cream, which is not FDA-approved. None of them avoids the blood tests used to diagnose and monitor treatment. 1,2,3,4,5,6
Is there an FDA-approved testosterone pill?
Yes — Kyzatrex, Jatenzo and Tlando are FDA-approved oral testosterone undecanoate capsules. They're taken with food. All three checked labels show the old blood-pressure boxed warning and age-related or nonstructural contraindication removed in July 2025; blood-pressure warnings and the stated age-related evidence limitation remain. 4,7,8
Is testosterone cream as effective as injections?
A compounded cream should not borrow the evidence for an FDA-approved gel. Approved topical products have evidence for their labeled uses, but that does not establish that any compounded cream works as well as injections. The practical differences include daily application, transfer risk to others, absorption and cost; response is assessed with symptoms, blood tests and the prescriber's review. 5,1,20
Does testosterone gel really transfer to other people?
Yes. FDA-approved testosterone gels carry a boxed warning about secondary exposure after reports of children developing enlarged genitals, early pubic hair and advanced bone age from skin contact. The label's precautions reduce that risk but have to be followed every day. Nasal gel and oral capsules carry no such warning. 1,3,4
Are testosterone pellets needle-free?
No. Pellets are implanted under the skin in an office procedure using injected local anesthetic and a small incision. They reduce self-injections. They are not needle-free. 12
Is the testosterone patch still available?
FDA lists Androderm as discontinued, so it is not a routine current U.S. option. Older articles still list it. The buccal system Striant was also discontinued. 36,37
Does needle-free TRT still affect fertility?
Yes. Any testosterone taken from outside the body can suppress sperm production regardless of format, and product labels warn that effects on fertility may be irreversible. Nasal testosterone has small, short-term trial data suggesting sperm measures were maintained in many participants, but it is not FDA-approved for preserving fertility. Do not treat those findings as a pregnancy or recovery guarantee. 4,26,27
Is enclomiphene the same as TRT?
No. Enclomiphene and clomiphene are SERMs that can stimulate the body's own testosterone production; they are not testosterone. Enclomiphene has no FDA-approved product and remains in Category 1 under evaluation in the FDA list checked here, not on the final 503A Bulks List. Conditional compounding policy is not FDA approval. Clomiphene's use for low testosterone in men is off-label. 15,34,13
Can I get TRT online without an in-person visit?
Sometimes. The temporary federal extension allows qualifying telemedicine prescribing without a prior in-person exam through December 31, 2026; testosterone under this pathway requires an audio-video visit and the other federal conditions. State rules and prescriber authority still apply, and some programs may still require an in-person exam. 46,47
Which needle-free option is cheapest?
A generic gel or solution through your own prescriber is worth pricing, but this research did not establish a universal cheapest complete care path. Compare the exact product and days supplied, then add visits, labs, memberships and shipping. A low coupon price is not a complete first-year quote. 39
Does insurance cover needle-free TRT?
Sometimes, but it depends on the exact medicine, your plan's formulary and any coverage requirements. Ask your plan about the specific drug name and strength, prior authorization, approved pharmacy, and the separate cost of visits and labs — not just "testosterone." Male Excel's terms go beyond not billing insurance: they say patients agree not to submit program charges for reimbursement. Do not assume you can pay that program in cash and claim the bill later. 44
Does a home blood test mean no needles?
No. A finger-prick home kit uses a lancet, and a visiting phlebotomist uses a needle. Home collection is a convenience, not proof of a needle-free test. If blood draws themselves are the problem, tell the clinic when you book so they can plan for it. 21
How long until needle-free TRT works?
That varies by person and product, and your prescriber will track symptoms as well as blood tests. Product labels direct clinicians to re-check testosterone after starting and periodically after that. A guaranteed timeline for specific results is not supported by those testing schedules. 20,1,4
Still not sure which TRT care route fits you? Use our free Find My TRT Path tool.
Where can you check the sources?
Prices, availability, drug labels and telemedicine rules change. This page carries a visible last-verified date and we update it when we re-check the underlying facts, not when we change the design. If something here is out of date or wrong, tell us through corrections and we'll fix it.
- AndroGel 1.62% prescribing information and Medication Guide, current label checked September 8, 2026. Return to first citation
- Testosterone topical solution prescribing information, current label checked September 8, 2026. Return to first citation
- Natesto prescribing information, current label checked September 8, 2026. Return to first citation
- Kyzatrex prescribing information, revised August 2026; sections 2, 5, 8.5, 12.3, 14 and product/package listings. Return to first citation
- FDA, Understanding the Risks of Compounded Drugs. Return to first citation
- Endocrine Society, Testosterone Therapy in Men With Hypogonadism: Clinical Practice Guideline. Return to first citation
- Jatenzo prescribing information, revised September 2025; current version checked September 8, 2026. Return to first citation
- Tlando prescribing information, revised February 2026; current version checked September 8, 2026. Return to first citation
- Drugs@FDA, Testim, application 021454; prescription marketing status. Return to first citation
- Drugs@FDA, Vogelxo, application 204399; prescription marketing status. Return to first citation
- Male Excel, Hormone Treatment Costs; provider-stated fees and product descriptions checked September 8, 2026. Return to first citation
- TESTOPEL manufacturer implantation guide; local-anesthetic injection and incision. Return to first citation
- Clomid prescribing information; FDA-approved use concerns ovulatory dysfunction in women desiring pregnancy. Return to first citation
- FDA, June 2022 Pharmacy Compounding Advisory Committee briefing slides; enclomiphene citrate and the 2015 complete response letter. Return to first citation
- FDA, Bulk Drug Substances Nominated for Use in Compounding Under Section 503A; Category 1 list updated May 14, 2026. Return to first citation
- Taurus Meds, Enclomiphene; provider-stated oral product checked September 8, 2026. Return to first citation
- DEA, Drug Scheduling; testosterone is listed in Schedule III. Return to first citation
- Drugs@FDA, Fortesta, application 021463; discontinued marketing status. Return to first citation
- Male Excel, Testosterone Lipoderm Cream; provider-stated formulation and program disclosures checked September 8, 2026. Return to first citation
- American Urological Association, Evaluation and Management of Testosterone Deficiency: AUA Guideline; Mulhall et al., Journal of Urology, 2018. Return to first citation
- Guy's and St Thomas' NHS Foundation Trust, Needle phobia and overcoming your fear. Return to first citation
- Male Excel, Frequently Asked Questions; provider-stated state exclusions, pharmacy partners, refill process and policies checked September 8, 2026. Return to first citation
- FDA, AndroGel safety-labeling approval letter, September 18, 2009; secondary exposure and reported outcomes. Return to first citation
- FDA, FDA issues class-wide labeling changes for testosterone products, February 28, 2025. Return to first citation
- HHS, FDA requests updates to testosterone therapy labeling, June 18, 2026. Return to first citation
- Ramasamy et al., Effect of Natesto on Reproductive Hormones, Semen Parameters and Hypogonadal Symptoms: A Single Center, Open Label, Single Arm Trial, Journal of Urology, 2020; PMID 32294396. Return to first citation
- AUA/ASRM, Diagnosis and Treatment of Infertility in Men, Part II; testosterone monotherapy and alternative medicines. Return to first citation
- Masterson et al., SAT-034: The Effect of Natesto on Spermatogenesis, Reproductive Hormones, and Hypogonadal Symptoms. A Phase IV Study, Journal of the Endocrine Society, 2020; companion conference abstract. Return to first citation
- Male Excel, Triclozene / clomiphene for men; provider-stated product description checked September 8, 2026. Return to first citation
- Hims, Testosterone care; enclomiphene-based offer and Kyzatrex launch wording checked September 8, 2026. Return to first citation
- Marius Pharmaceuticals, Hims & Hers collaboration announcement, September 10, 2025. Return to first citation
- Pregnyl prescribing information; selected male hypogonadotropic hypogonadism indication and injection format. Return to first citation
- FDA, June 2022 Pharmacy Compounding Advisory Committee meeting minutes; enclomiphene vote. Return to first citation
- FDA, Bulk Drug Substances Used in Compounding Under Section 503A of the FD&C Act; interim policy and category distinctions. Return to first citation
- XYOSTED manufacturer Instructions for Use; needle end and injection. Return to first citation
- Drugs@FDA, Androderm, application 020489; discontinued status and safety/effectiveness determination. Return to first citation
- Drugs@FDA, Striant, application 021543; discontinued marketing status. Return to first citation
- FDA, Important Reminders about Registration and Listing; registration is not approval or clearance. Return to first citation
- GoodRx, Testosterone prices; quantity-specific discount listings checked September 8, 2026. Return to first citation
- GoodRx, AndroGel prices; default generic selection checked September 8, 2026. Return to first citation
- GoodRx, Natesto prices; three 11-g dispensers checked September 8, 2026. Return to first citation
- GoodRx, Jatenzo prices; 60 capsules at 237 mg checked September 8, 2026. Return to first citation
- Natesto, Support and Resources; manufacturer savings and cash-option terms checked September 8, 2026. Return to first citation
- Male Excel, Terms and Conditions; payment, subscriptions, shipping, availability and all-sales-final terms checked September 8, 2026. Return to first citation
- ASHP / University of Utah Drug Information Service, Testosterone Cypionate Injection shortage bulletin, updated September 3, 2026. Return to first citation
- DEA, DEA Extends Telemedicine Flexibilities to Ensure Continued Access to Care, December 31, 2025. Return to first citation
- Federal Register, Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications, December 31, 2025. Return to first citation
- Endocrine Society, Statement on Testosterone Replacement Therapy, July 16, 2026. Return to first citation
- Taurus Meds, Testosterone program page; gel card and product-description limitation checked September 8, 2026. Return to first citation
Ready to explore your options?
Our tool helps you narrow down the care route that fits your situation based on testing, budget, and fertility goals.
Find My TRT Path